Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
- Publication Information:
Original Publication: [London] : Nature Pub. Group
- Subject Terms:
- Abstract:
Self-assembling natural drug hydrogels formed without structural modification and able to act as carriers are of interest for biomedical applications. A lack of knowledge about natural drug gels limits there current application. Here, we report on rhein, a herbal natural product, which is directly self-assembled into hydrogels through noncovalent interactions. This hydrogel shows excellent stability, sustained release and reversible stimuli-responses. The hydrogel consists of a three-dimensional nanofiber network that prevents premature degradation. Moreover, it easily enters cells and binds to toll-like receptor 4. This enables rhein hydrogels to significantly dephosphorylate IκBα, inhibiting the nuclear translocation of p65 at the NFκB signalling pathway in lipopolysaccharide-induced BV2 microglia. Subsequently, rhein hydrogels alleviate neuroinflammation with a long-lasting effect and little cytotoxicity compared to the equivalent free-drug in vitro. This study highlights a direct self-assembly hydrogel from natural small molecule as a promising neuroinflammatory therapy.
- Comments:
Erratum in: Nat Commun. 2020 Jul 27;11(1):3815. (PMID: 32719450)
- References:
Ageing Res Rev. 2017 Jul;36:11-19. (PMID: 28235660)
J Am Chem Soc. 2016 Jan 27;138(3):704-17. (PMID: 26741786)
Chem Soc Rev. 2017 Oct 30;46(21):6600-6620. (PMID: 28828455)
Curr Drug Deliv. 2016;13(1):4-26. (PMID: 26279117)
Nat Chem. 2015 Jan;7(1):73-81. (PMID: 25515893)
Nat Chem. 2014 Jun;6(6):511-8. (PMID: 24848237)
Chem Soc Rev. 2013 Jan 7;42(1):156-72. (PMID: 23032970)
J Am Chem Soc. 2009 Sep 30;131(38):13576-7. (PMID: 19731909)
Nat Rev Drug Discov. 2015 Feb;14(2):111-29. (PMID: 25614221)
Cell Death Dis. 2017 Aug 17;8(8):e3004. (PMID: 28817116)
Chem Soc Rev. 2017 Oct 30;46(21):6430-6432. (PMID: 29034939)
Biomed Chromatogr. 2014 Apr;28(4):564-72. (PMID: 24136708)
ACS Nano. 2018 Apr 24;12(4):3295-3310. (PMID: 29558107)
Xenobiotica. 2015 Apr;45(4):361-72. (PMID: 25815638)
Biomaterials. 2012 Aug;33(24):5848-53. (PMID: 22607913)
Int Immunopharmacol. 2017 Sep;50:14-21. (PMID: 28622577)
J Am Chem Soc. 2018 May 23;140(20):6467-6473. (PMID: 29733593)
J Nat Prod. 2016 Mar 25;79(3):629-61. (PMID: 26852623)
BMC Complement Altern Med. 2017 Mar 7;17(1):140. (PMID: 28264680)
Sci Rep. 2016 Nov 30;6:37098. (PMID: 27901023)
J Appl Toxicol. 2015 Dec;35(12):1539-49. (PMID: 25677194)
J Am Chem Soc. 2013 Sep 11;135(36):13379-86. (PMID: 23984683)
Adv Mater. 2016 Aug;28(31):6680-6. (PMID: 27214390)
Chem Soc Rev. 2017 Oct 30;46(21):6638-6663. (PMID: 29019492)
Angew Chem Int Ed Engl. 2015 Jun 26;54(27):7944-8. (PMID: 26012538)
J Am Chem Soc. 2013 Feb 27;135(8):2907-10. (PMID: 23379791)
Dalton Trans. 2016 Nov 22;45(46):18438-18442. (PMID: 27819371)
J Asian Nat Prod Res. 2013 Jul;15(7):756-63. (PMID: 23777400)
Nat Rev Neurol. 2017 Jul;13(7):420-433. (PMID: 28524175)
J Am Chem Soc. 2013 Jan 16;135(2):542-5. (PMID: 23136972)
Nanoscale. 2016 Mar 28;8(12):6479-83. (PMID: 26948898)
Brain Behav Immun. 2017 Mar;61:326-339. (PMID: 28007523)
Nanoscale. 2017 Nov 23;9(45):17717-17721. (PMID: 29130461)
Cytokine. 2008 May;42(2):145-151. (PMID: 18304834)
Chem Soc Rev. 2017 May 9;46(9):2421-2436. (PMID: 28357433)
J Biol Chem. 2015 May 15;290(20):12899-907. (PMID: 25847243)
Adv Mater. 2018 May;30(20):e1705912. (PMID: 29602270)
J Agric Food Chem. 2017 Jan 18;65(2):373-382. (PMID: 28032996)
J Neurosci. 2015 Jun 3;35(22):8411-22. (PMID: 26041910)
Chem Soc Rev. 2017 Oct 30;46(21):6532-6552. (PMID: 28820527)
Anal Chem. 2014 Feb 18;86(4):2193-9. (PMID: 24467604)
Chem Soc Rev. 2018 Sep 17;47(18):6917-6929. (PMID: 29697128)
Small. 2018 Apr;14(15):e1704039. (PMID: 29479856)
Eur J Pharm Sci. 2017 Jan 1;96:390-397. (PMID: 27721042)
Adv Mater. 2015 Jan 27;27(4):648-54. (PMID: 25447243)
Adv Mater. 2010 May 18;22(19):2159-63. (PMID: 20564253)
Nat Commun. 2018 May 18;9(1):1991. (PMID: 29777137)
ACS Appl Mater Interfaces. 2018 Feb 7;10(5):4530-4539. (PMID: 29336146)
Chem Soc Rev. 2009 Apr;38(4):883-91. (PMID: 19421568)
Nat Chem Biol. 2012 Aug;8(8):701-6. (PMID: 22706200)
Langmuir. 2005 Feb 1;21(3):1067-73. (PMID: 15667191)
Anal Chem. 2015 Aug 4;87(15):7958-63. (PMID: 26153916)
Nano Today. 2016 Feb;11(1):13-30. (PMID: 27066106)
Chem Commun (Camb). 2014 Aug 25;50(66):9413-5. (PMID: 25007863)
Nat Nanotechnol. 2016 Nov;11(11):960-967. (PMID: 27694850)
- Accession Number:
0 (Anthraquinones)
0 (Anti-Inflammatory Agents)
0 (Delayed-Action Preparations)
0 (Drug Carriers)
0 (Hydrogels)
0 (Lipopolysaccharides)
0 (Nfkbia protein, mouse)
0 (Phytochemicals)
0 (Rela protein, mouse)
0 (Tlr4 protein, mouse)
0 (Toll-Like Receptor 4)
0 (Transcription Factor RelA)
139874-52-5 (NF-KappaB Inhibitor alpha)
YM64C2P6UX (rhein)
- Publication Date:
Date Created: 20190410 Date Completed: 20190610 Latest Revision: 20200728
- Publication Date:
20240829
- Accession Number:
PMC6453967
- Accession Number:
10.1038/s41467-019-09601-3
- Accession Number:
30962431
No Comments.